Citation Impact
Citing Papers
Diabetes and Cardiovascular Disease
1999 Standout
Diet and Lifestyle Recommendations Revision 2006
2006 Standout
Studies on acyl-coenzyme A: cholesterol acyltransferase activity in human liver microsomes.
1989
Mechanism of degradation of the steroid side chain in the formation of bile acids.
1992
Thiazolidinediones
2004 Standout
Mechanisms of Thrombus Formation
2008 Standout
Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal Women
1998 Standout
Role of peroxisome proliferators-activated receptors in the pathogenesis and treatment of nonalcoholic fatty liver disease
2008
Hemostatic factors according to menopausal status and use of hormone replacement therapy
1992
REGULATION OF BILE ACID BIOSYNTHESIS
1999
Mechanisms linking obesity with cardiovascular disease
2006 StandoutNature
Nonfasting Triglycerides and Risk of Myocardial Infarction, Ischemic Heart Disease, and Death in Men and Women
2007 Standout
By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease?
1994
Dietary saturated fats and their food sources in relation to the risk of coronary heart disease in women
1999
Selected major risk factors and global and regional burden of disease
2002 Standout
The Protective Effects of Estrogen on the Cardiovascular System
1999 Standout
Effect of an increased intake of α-linolenic acid and group nutritional education on cardiovascular risk factors: the Mediterranean Alpha-linolenic Enriched Groningen Dietary Intervention (MARGARIN) study
2002
Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes
2007 Standout
Nutritional quality and health benefits of chickpea (Cicer arietinumL.): a review
2012 Standout
Whole blood coagulation on protein adsorption-resistant PEG and peptide functionalised PEG-coated titanium surfaces
2004 StandoutNobel
Rationale and design of the Department of Veterans Affairs high-density lipoprotein cholesterol Intervention Trial (HIT) for secondary prevention of coronary artery disease in men with low high-density lipoprotein cholesterol and desirable low-density lipoprotein cholesterol
1993
Essential fatty acids in health and chronic disease
1999
Targeted Disruption of the Nuclear Receptor FXR/BAR Impairs Bile Acid and Lipid Homeostasis
2000 Standout
Principal components analysis corrects for stratification in genome-wide association studies
2006 Standout
Cardiovascular Effects of n-3 Fatty Acids
1988 Standout
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials
2010 Standout
Cell and molecular biology of the assembly and secretion of apolipoprotein B-containing lipoproteins by the liver
1999
Factor VII activation and menopausal status
1990
Role of Oxidative Modifications in Atherosclerosis
2004 Standout
Dietary fatty acids in human thrombosis and hemostasis
1997
Obesity, haemostasis and the fibrinolytic system
2002
Fish Intake, Contaminants, and Human Health
2006 Standout
HMG-CoA reductase inhibitors are associated with reduced mortality in ESRD patients
2002
Premature Atherosclerosis in Patients with Familial Chylomicronemia Caused by Mutations in the Lipoprotein Lipase Gene
1996
Meat Intake and Mortality
2009
Effect of a Mediterranean-Style Diet on Endothelial Dysfunction and Markers of Vascular Inflammation in the Metabolic Syndrome
2004 Standout
Regulatory Functions of the Vascular Endothelium
1990 StandoutNobel
PPARγ signaling and metabolism: the good, the bad and the future
2013 Standout
Explaining the Decrease in U.S. Deaths from Coronary Disease, 1980–2000
2007 Standout
Effect of Metformin and Rosiglitazone Combination Therapy in Patients With Type 2 Diabetes Mellitus
2000
Cardiorespiratory Fitness as a Quantitative Predictor of All-Cause Mortality and Cardiovascular Events in Healthy Men and Women
2009 Standout
Obesity as a medical problem
2000 StandoutNature
Antiatherothrombotic Properties of Statins
1998
Gemfibrozil for the Secondary Prevention of Coronary Heart Disease in Men with Low Levels of High-Density Lipoprotein Cholesterol
1999 Standout
Importance of n−3 fatty acids in health and disease
2000
The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
1992 Standout
Detrimental Impact of Trans Fats on Human Health: Stearic Acid‐Rich Fats as Possible Substitutes
2008
Lipids and thyroid hormones
1988
Atherosclerosis
2001 Standout
Lipid oxidation and improving the oxidative stability
2010 Standout
Reduction of Serum Cholesterol with Sitostanol-Ester Margarine in a Mildly Hypercholesterolemic Population
1995 Standout
The possible role of postprandial hyperglycaemia in the pathogenesis of diabetic complications
2003
Adipose Tissue as an Endocrine Organ
2004 Standout
Activation of Oxidative Stress by Acute Glucose Fluctuations Compared With Sustained Chronic Hyperglycemia in Patients With Type 2 Diabetes
2006 Standout
Prediction of Cardiovascular Events and All-Cause Mortality With Arterial Stiffness
2010 Standout
Atorvastatin in Patients with Type 2 Diabetes Mellitus Undergoing Hemodialysis
2005 Standout
Oxidative damage and mitochondrial decay in aging.
1994 Standout
Diagnosis and Management of the Metabolic Syndrome
2005 Standout
Association of Hormone Replacement Therapy With Hemostatic and Other Cardiovascular Risk Factors
1995
Role of Endothelial Dysfunction in Atherosclerosis
2004 Standout
AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 Update
2006 Standout
Dietary lipids and thrombosis. Relationships to atherosclerosis.
1990
Are Increased Plasma Non-Esterified Fatty Acid Concentrations a Risk Marker for Coronary Heart Disease and other Chronic Diseases?
1996
Domain structure of 3-hydroxy-3-methylglutaryl coenzyme A reductase, a glycoprotein of the endoplasmic reticulum.
1985 StandoutNobel
Association of Dietary Fish and n-3 Fatty Acid Intake With Hemostatic Factors in the Coronary Artery Risk Development in Young Adults (CARDIA) Study
1998
Acyl-coenzyme A:Cholesterol acyltransferase in human liver. In vitro detection and some characteristics of the enzyme
1980
3-Hydroxy-3-methylglutaryl-coenzyme A reductase
1982
Triggering of Acute Cardiovascular Disease and Potential Preventive Strategies
2006
Primary Prevention of Coronary Heart Disease: Guidance From Framingham
1998
Dietary and Policy Priorities for Cardiovascular Disease, Diabetes, and Obesity
2016 Standout
ACAT2 Is Localized to Hepatocytes and Is the Major Cholesterol-Esterifying Enzyme in Human Liver
2004 StandoutNobel
Effects of Estrogen or Estrogen/ Progestin Regimens on Heart Disease Risk Factors in Postmenopausal Women
1995 Standout
The submicrosomal localization of acyl-coenzyme A–cholesterol acyltransferase and its substrate, and of cholesteryl esters in rat liver
1978
Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55 000 vascular deaths
2007 Standout
Effect of dietary n-3 fatty acids on HMG-CoA reductase and ACAT activities in liver and intestine of the rabbit.
1986
Plasma Fatty Acid Composition as a Predictor of Arterial Stiffness and Mortality
2009
Reversible accumulation of cholesteryl esters in macrophages incubated with acetylated lipoproteins.
1979 StandoutNobel
Particulate Matter Air Pollution and Cardiovascular Disease
2010 Standout
Meat consumption, health, and the environment
2018 StandoutScience
Lowering LDL Cholesterol
1999
Quantitation of activated factor VII levels in plasma using a tissue factor mutant selectively deficient in promoting factor VII activation
1993
Contact System: A Vascular Biology Modulator With Anticoagulant, Profibrinolytic, Antiadhesive, and Proinflammatory Attributes
1997
Associations of fish intake and dietary n-3 polyunsaturated fatty acids with a hypocoagulable profile. The Atherosclerosis Risk in Communities (ARIC) Study.
1993
Interplay Between Different Polyunsaturated Fatty Acids and Risk of Coronary Heart Disease in Men
2005
Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines
2004 Standout
Fish Consumption, Fish Oil, Omega-3 Fatty Acids, and Cardiovascular Disease
2002 Standout
Contribution of Factor VII Genotype to Activated FVII Levels
1997
Structure of the Sec23p/24p and Sec13p/31p complexes of COPII
2001 StandoutNobel
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins
2005 Standout
Early high-dose lipid-lowering therapy to avoid cardiac events: a systematic review and economic evaluation
2009
Dietary Fish Oil (4 g Daily) and Cardiovascular Risk Markers in Healthy Men
1997
Works of K.A. Mitropoulos being referenced
Randomized placebo-controlled study of the effects of simvastatin on haemostatic variables, lipoproteins and free fatty acids
1997
Factor VII and Dietary Fat Intake
1990
Hypercoagulability and Factor VII in Hypertriglyceridemia
1988
Factor VII coagulant activity is strongly associated with the plasma concentration of large lipoprotein particles in middle-aged men
1989
Lipolysis of triglyceride-rich lipoproteins activates coagulant factor XII: A study in familial lipoprotein-lipase deficiency
1992
Fat consumption and factor VII coagulant activity in middle-aged men An association between a dietary and thrombogenic coronary risk factor
1989
Metabolism of apolipoprotein B-100 and of triglyceride-rich lipoprotein particles in the absence of functional lipoprotein lipase
1993
Plasma factor VII is activated by postprandial triglyceridaemia, irrespective of dietary fat composition
1991
Dietary fat induces changes in factor VII coagulant activity through effects on plasma free stearic acid concentration.
1994
Increased factor VII coagulant activity in the rabbit following diet-induced hypercholesterolaemia
1987
Acyl-Coenzyme A—Cholesterol Acyltransferase Activity in Human Liver
1979
The Increased Rate of Activation of Factor XII in Late Pregnancy Can Contribute to the Increased Reactivity of Factor VII
1990
The formation of cholest-5-ene-3β,26-diol as an intermediate in the conversion of cholesterol into bile acids by liver mitochondria
1972
The role of glucocorticoids in the regulation of the diurnal rhythm of hepatic β-hydroxy-β-methylglutaryl-coenzyme A reductase and cholesterol 7α-hydroxylase
1976
Influence ofn-6versusn-3Polyunsaturated Fatty Acids in Diets Low in Saturated Fatty Acids on Plasma Lipoproteins and Hemostatic Factors
1997
On the mechanism of regulation of hepatic 3-hydroxy-3-methylglutaryl coenzyme a reductase and of acyl coenzyme A: Cholesterol acyltransferase by dietary fat
1980
Compartmentation and Supply of Cholesterol: Two Important Factors in the Co-ordinate Regulation of Hydroxymethylglutaryl-CoA Reductase and Cholesterol 7α-Hydroxylase
1978